Therapeutic Peptide Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551609 No. of Pages: 78 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Polypeptide molecules are ideal drug molecules due to their high affinity, high selectivity, low toxicity and easy synthesis.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Peptide. This report contains market size and forecasts of Therapeutic Peptide in global, including the following market information:
Global Therapeutic Peptide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Therapeutic Peptide Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Therapeutic Peptide companies in 2022 (%)
The global Therapeutic Peptide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Peptide include AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Peptide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Peptide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Peptide Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
Other
Global Therapeutic Peptide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Peptide Market Segment Percentages, by Application, 2022 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Therapeutic Peptide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Peptide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Peptide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Therapeutic Peptide revenues share in global market, 2022 (%)
Key companies Therapeutic Peptide sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Therapeutic Peptide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
Ipsen
Eli Lilly
Merck
Novo Nordisk
Novartis
Johnson and Johnson
Sanofi
Teva
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Peptide, market overview.
Chapter 2: Global Therapeutic Peptide market size in revenue and volume.
Chapter 3: Detailed analysis of Therapeutic Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Therapeutic Peptide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Peptide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Peptide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Peptide Overall Market Size
2.1 Global Therapeutic Peptide Market Size: 2022 VS 2029
2.2 Global Therapeutic Peptide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Therapeutic Peptide Sales: 2018-2029
3 Company Landscape
3.1 Top Therapeutic Peptide Players in Global Market
3.2 Top Global Therapeutic Peptide Companies Ranked by Revenue
3.3 Global Therapeutic Peptide Revenue by Companies
3.4 Global Therapeutic Peptide Sales by Companies
3.5 Global Therapeutic Peptide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Therapeutic Peptide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Therapeutic Peptide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Peptide Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Peptide Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Peptide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Peptide Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.1.4 Other
4.2 By Type - Global Therapeutic Peptide Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Peptide Revenue, 2018-2023
4.2.2 By Type - Global Therapeutic Peptide Revenue, 2024-2029
4.2.3 By Type - Global Therapeutic Peptide Revenue Market Share, 2018-2029
4.3 By Type - Global Therapeutic Peptide Sales & Forecasts
4.3.1 By Type - Global Therapeutic Peptide Sales, 2018-2023
4.3.2 By Type - Global Therapeutic Peptide Sales, 2024-2029
4.3.3 By Type - Global Therapeutic Peptide Sales Market Share, 2018-2029
4.4 By Type - Global Therapeutic Peptide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Peptide Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application - Global Therapeutic Peptide Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Peptide Revenue, 2018-2023
5.2.2 By Application - Global Therapeutic Peptide Revenue, 2024-2029
5.2.3 By Application - Global Therapeutic Peptide Revenue Market Share, 2018-2029
5.3 By Application - Global Therapeutic Peptide Sales & Forecasts
5.3.1 By Application - Global Therapeutic Peptide Sales, 2018-2023
5.3.2 By Application - Global Therapeutic Peptide Sales, 2024-2029
5.3.3 By Application - Global Therapeutic Peptide Sales Market Share, 2018-2029
5.4 By Application - Global Therapeutic Peptide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Therapeutic Peptide Market Size, 2022 & 2029
6.2 By Region - Global Therapeutic Peptide Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Peptide Revenue, 2018-2023
6.2.2 By Region - Global Therapeutic Peptide Revenue, 2024-2029
6.2.3 By Region - Global Therapeutic Peptide Revenue Market Share, 2018-2029
6.3 By Region - Global Therapeutic Peptide Sales & Forecasts
6.3.1 By Region - Global Therapeutic Peptide Sales, 2018-2023
6.3.2 By Region - Global Therapeutic Peptide Sales, 2024-2029
6.3.3 By Region - Global Therapeutic Peptide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Therapeutic Peptide Revenue, 2018-2029
6.4.2 By Country - North America Therapeutic Peptide Sales, 2018-2029
6.4.3 US Therapeutic Peptide Market Size, 2018-2029
6.4.4 Canada Therapeutic Peptide Market Size, 2018-2029
6.4.5 Mexico Therapeutic Peptide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Therapeutic Peptide Revenue, 2018-2029
6.5.2 By Country - Europe Therapeutic Peptide Sales, 2018-2029
6.5.3 Germany Therapeutic Peptide Market Size, 2018-2029
6.5.4 France Therapeutic Peptide Market Size, 2018-2029
6.5.5 U.K. Therapeutic Peptide Market Size, 2018-2029
6.5.6 Italy Therapeutic Peptide Market Size, 2018-2029
6.5.7 Russia Therapeutic Peptide Market Size, 2018-2029
6.5.8 Nordic Countries Therapeutic Peptide Market Size, 2018-2029
6.5.9 Benelux Therapeutic Peptide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Therapeutic Peptide Revenue, 2018-2029
6.6.2 By Region - Asia Therapeutic Peptide Sales, 2018-2029
6.6.3 China Therapeutic Peptide Market Size, 2018-2029
6.6.4 Japan Therapeutic Peptide Market Size, 2018-2029
6.6.5 South Korea Therapeutic Peptide Market Size, 2018-2029
6.6.6 Southeast Asia Therapeutic Peptide Market Size, 2018-2029
6.6.7 India Therapeutic Peptide Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Therapeutic Peptide Revenue, 2018-2029
6.7.2 By Country - South America Therapeutic Peptide Sales, 2018-2029
6.7.3 Brazil Therapeutic Peptide Market Size, 2018-2029
6.7.4 Argentina Therapeutic Peptide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Peptide Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Therapeutic Peptide Sales, 2018-2029
6.8.3 Turkey Therapeutic Peptide Market Size, 2018-2029
6.8.4 Israel Therapeutic Peptide Market Size, 2018-2029
6.8.5 Saudi Arabia Therapeutic Peptide Market Size, 2018-2029
6.8.6 UAE Therapeutic Peptide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Therapeutic Peptide Major Product Offerings
7.1.4 AbbVie Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Therapeutic Peptide Major Product Offerings
7.2.4 AstraZeneca Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Ipsen
7.3.1 Ipsen Company Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Therapeutic Peptide Major Product Offerings
7.3.4 Ipsen Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.3.5 Ipsen Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Therapeutic Peptide Major Product Offerings
7.4.4 Eli Lilly Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Therapeutic Peptide Major Product Offerings
7.5.4 Merck Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Novo Nordisk
7.6.1 Novo Nordisk Company Summary
7.6.2 Novo Nordisk Business Overview
7.6.3 Novo Nordisk Therapeutic Peptide Major Product Offerings
7.6.4 Novo Nordisk Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.6.5 Novo Nordisk Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Therapeutic Peptide Major Product Offerings
7.7.4 Novartis Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Therapeutic Peptide Major Product Offerings
7.8.4 Johnson and Johnson Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.8.5 Johnson and Johnson Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Therapeutic Peptide Major Product Offerings
7.9.4 Sanofi Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Teva
7.10.1 Teva Company Summary
7.10.2 Teva Business Overview
7.10.3 Teva Therapeutic Peptide Major Product Offerings
7.10.4 Teva Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.10.5 Teva Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Therapeutic Peptide Business Overview
7.11.3 Takeda Therapeutic Peptide Major Product Offerings
7.11.4 Takeda Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.11.5 Takeda Key News & Latest Developments
8 Global Therapeutic Peptide Production Capacity, Analysis
8.1 Global Therapeutic Peptide Production Capacity, 2018-2029
8.2 Therapeutic Peptide Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Peptide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Peptide Supply Chain Analysis
10.1 Therapeutic Peptide Industry Value Chain
10.2 Therapeutic Peptide Upstream Market
10.3 Therapeutic Peptide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Peptide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com